• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

sunshine law

  1. Toxic Work Culture Forcing Loyal Employees to Flee

    Leadership we all know we’ve had people leave in all areas of biologics division at record numbers. Some said they weren’t leaving for better pay or promotion but dysfunction and toxic state within division led people who had been fully committed to Ilumya to leave. An even bigger red flag is...
  2. When did psoriasis become aesthetics on social media?

    I’m use to seeing all the docs posting about Botox, filler in butts, big lips, and all that cash business stuff but when did it start to become the norm for docs/offices doing IG videos on Skyrizi and posting about it? Is this even compliant? It seems like kickback time. Very sketchy. I don’t...